TYRA-300, an FGFR3-selective inhibitor, promotes bone growth in two FGFR3-driven models of chondrodysplasia
Starrett J,Lemoine C,Guillo M,Fayad C,Kaci N,Neal M,Pettitt E,Pache M,Ye Q,Chouinard M,Allen E,Baujat G,Hudkins R,Bober M,Harris T,Swanson R,Legeai-Mallet L
Source :
2025 Apr 3
Pmid / DOI:
10.1172/jci.insight.189307